CEDOC team led by Gabriela Silva, from the Gene Therapy Lab at CEDOC, was distinguished by Prémio Janssen Inovação,for the project “Aliskiren as a new therapeutic approach for the treatment of diabetic retinopathy”.
This award is a joint initiative from Janssen Portugal and Universidade Católica Portuguesa that aims to foster and distinguish outstanding research in nationals institutes.